Liraglutide for patients with non-alcoholic steatohepatitis.
The Article by Matthew Armstrong and colleagues (Feb 13, p 679) reports different outcomes to those initially registered in the trial protocol.
| 主要な著者: | , , |
|---|---|
| フォーマット: | Journal article |
| 言語: | English |
| 出版事項: |
Elsevier
2016
|